Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lu Shan

Showing results (91-100 of 193) with videos related to

Pageof 20
Sort By:
Atherosclerosis|April 13, 2013
Janus-like role of fibroblast growth factor 2 in arteriosclerotic coronary artery disease: atherogenesis and angiogenesisMi-Hua Liu, Zhi-Han Tang, Guo-Hua Li, et al.
Reproductive Toxicology (Elmsford, N.Y.)|May 28, 2023
MicroRNA‑30a‑5p regulates cypermethrin-induced apoptosis of Sertoli cells by targeting KLF9 in vitroQi Wang, Jia-Fei Xie, Ting-Ting Yao, et al.
Journal of Cellular Physiology|September 25, 2018
PCSK9: A novel inflammation modulator in atherosclerosis?Zhi-Han Tang, Tao-Hua Li, Juan Peng, et al.
Toxicology Research|September 2, 2022
Cypermethrin inhibits proliferation of Sertoli cells through AR involving DAB2IP/PI3K/AKT signaling pathway in vitroQi Wang, Xu-Xu Wang, Jia-Fei Xie, et al.
Drug Design, Development and Therapy|February 13, 2016
Formulation, optimization, and pharmacodynamic evaluation of chitosan/phospholipid/β-cyclodextrin microspheresLu Shan, En-Xue Tao, Qing-Hui Meng, et al.
Frontiers in Cardiovascular Medicine|August 29, 2022
Development of hydrogen sulfide donors for anti-atherosclerosis therapeutics research: Challenges and future prioritiesYe-Wei Yang, Nian-Hua Deng, Kai-Jiang Tian, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 21, 2018
Endothelial to mesenchymal transition in atherosclerotic vascular remodelingYa-Meng Hao, Hou-Qin Yuan, Zhong Ren, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 19, 2022
PCSK9: A emerging participant in heart failureQian Xu, Yi-Meng Zhao, Nai-Qi He, et al.
Combinatorial Chemistry & High Throughput Screening|April 11, 2022
Identification of Alternative Splicing and LncRNA Genes in Brain Tissues of Fetal Mice at Different Developmental StagesFang Fu, Kun Du, Ying-Si Li, et al.
Acta Pharmacologica Sinica|May 30, 2017
The regioselective glucuronidation of morphine by dimerized human UGT2B7, 1A1, 1A9 and their allelic variantsZi-Zhao Yang, Li Li, Lu Wang, et al.
Pageof 20

Showing results (91-100 of 193) with videos related to

Sort By:
Pageof 20
Atherosclerosis|April 13, 2013
Janus-like role of fibroblast growth factor 2 in arteriosclerotic coronary artery disease: atherogenesis and angiogenesisMi-Hua Liu, Zhi-Han Tang, Guo-Hua Li, et al.
Reproductive Toxicology (Elmsford, N.Y.)|May 28, 2023
MicroRNA‑30a‑5p regulates cypermethrin-induced apoptosis of Sertoli cells by targeting KLF9 in vitroQi Wang, Jia-Fei Xie, Ting-Ting Yao, et al.
Journal of Cellular Physiology|September 25, 2018
PCSK9: A novel inflammation modulator in atherosclerosis?Zhi-Han Tang, Tao-Hua Li, Juan Peng, et al.
Toxicology Research|September 2, 2022
Cypermethrin inhibits proliferation of Sertoli cells through AR involving DAB2IP/PI3K/AKT signaling pathway in vitroQi Wang, Xu-Xu Wang, Jia-Fei Xie, et al.
Drug Design, Development and Therapy|February 13, 2016
Formulation, optimization, and pharmacodynamic evaluation of chitosan/phospholipid/β-cyclodextrin microspheresLu Shan, En-Xue Tao, Qing-Hui Meng, et al.
Frontiers in Cardiovascular Medicine|August 29, 2022
Development of hydrogen sulfide donors for anti-atherosclerosis therapeutics research: Challenges and future prioritiesYe-Wei Yang, Nian-Hua Deng, Kai-Jiang Tian, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 21, 2018
Endothelial to mesenchymal transition in atherosclerotic vascular remodelingYa-Meng Hao, Hou-Qin Yuan, Zhong Ren, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 19, 2022
PCSK9: A emerging participant in heart failureQian Xu, Yi-Meng Zhao, Nai-Qi He, et al.
Combinatorial Chemistry & High Throughput Screening|April 11, 2022
Identification of Alternative Splicing and LncRNA Genes in Brain Tissues of Fetal Mice at Different Developmental StagesFang Fu, Kun Du, Ying-Si Li, et al.
Acta Pharmacologica Sinica|May 30, 2017
The regioselective glucuronidation of morphine by dimerized human UGT2B7, 1A1, 1A9 and their allelic variantsZi-Zhao Yang, Li Li, Lu Wang, et al.
Pageof 20